Spravato vs. Ketamine Therapy: Benefits, Risks and the Potential for Misuse
Ketamine-based treatments have become one of the most discussed developments in mental health care. People living with treatment-resistant depression may hear about Spravato, ketamine infusions, ketamine-assisted therapy, compounded ketamine lozenges, or online programs offering ketamine products for use at home.
These treatments are often discussed as though they are interchangeable. They are not.
Spravato is an FDA-approved prescription nasal spray containing esketamine. Ketamine is an established anesthetic that may also be used off-label in certain clinical settings. Compounded ketamine products operate under a different regulatory framework, and recreational ketamine use exists outside legitimate medical treatment entirely.
The distinction has become even more important in 2026. On June 23, 2026, the U.S. Food and Drug Administration issued multiple warning letters involving websites marketing unapproved ketamine products, including ketamine troches and nasal sprays promoted for psychiatric conditions.
What Is Ketamine?
Ketamine is a dissociative anesthetic that has been used in medicine for decades. It primarily affects the brain’s glutamate system, including activity at NMDA receptors, and can influence pain processing, consciousness, perception, mood, memory, and awareness of the body and surrounding environment.
Ketamine is FDA-approved as an anesthetic. It is not FDA-approved specifically for the treatment of psychiatric disorders. Clinicians may nevertheless use FDA-approved medications for off-label purposes when they determine that doing so is medically appropriate.
That distinction is important because someone may receive legitimate ketamine treatment for depression even though ketamine itself does not have an FDA psychiatric indication. It does not mean every product advertised as “ketamine therapy” has the same evidence, medical oversight, safety procedures, or regulatory status.
What Is Spravato?
Spravato is the brand name for esketamine nasal spray. Esketamine is chemically related to ketamine, but Spravato should not be described simply as ordinary ketamine in a branded bottle.
Spravato has specific FDA-approved uses involving depression in adults. Current FDA labeling includes treatment-resistant depression in adults, either as monotherapy or together with an oral antidepressant, as well as depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior when used with an oral antidepressant.
Spravato is available only through a restricted Risk Evaluation and Mitigation Strategy, or REMS. It is administered in a certified healthcare setting under direct observation, and patients are monitored after administration.
Spravato vs. Ketamine: What Is the Difference?
| Treatment | What It Is | Important Considerations |
|---|---|---|
| Spravato | FDA-approved intranasal esketamine | Used for specific depression indications within a restricted REMS program and administered under healthcare supervision. |
| Ketamine Infusion | Ketamine administered intravenously, generally off-label when used for depression or certain pain conditions | Ketamine itself is FDA-approved as an anesthetic, not specifically as a psychiatric medication. |
| Compounded Ketamine | Ketamine prepared by a compounding pharmacy in forms such as troches, lozenges, or other formulations | Compounded medications do not undergo the same FDA premarket approval process as FDA-approved drugs. |
| Recreational Ketamine | Nonmedical ketamine use for intoxication or dissociation | May involve unpredictable dosing, frequent use, polysubstance use, accidents, addiction, and serious physical complications. |
Why This Matters in 2026
Rapid interest in ketamine has created a major consumer-information gap. Online advertising can make several very different treatment models look similar, even when the medications, prescribing practices, supervision, and regulatory requirements are not the same.
FDA enforcement in June 2026 highlighted that problem. The agency issued multiple warning letters to online sellers offering unapproved ketamine products, including troches and nasal sprays. FDA specifically reiterated that approved ketamine products are indicated as anesthetics and that ketamine is not FDA-approved for psychiatric disorders.
At the same time, FDA continues to recognize an approved medical role for esketamine through Spravato. That contrast is what makes the topic important: a medication can have legitimate clinical uses while still requiring safeguards because of serious side effects and abuse potential.
Why Are Spravato and Ketamine Used for Depression?
One reason ketamine-related treatments have attracted attention is the possibility of relatively rapid improvement in depressive symptoms for some patients. This is particularly relevant for people whose symptoms have persisted despite previous treatment.
Spravato provides another evidence-based option for appropriately selected adults with treatment-resistant depression. Research continues to examine how esketamine fits into longer-term care.
But improvement from a medication and long-term mental health recovery are not necessarily the same thing. Depression can involve biological, psychological, interpersonal, behavioral, environmental, and social factors. Medication may be one component of care while psychotherapy, behavioral changes, healthy routines, social support, and treatment of co-occurring conditions remain important.
What About Ketamine for Chronic Pain?
Ketamine has also been used or investigated for certain chronic pain conditions because NMDA receptors play a role in pain processing and nervous-system sensitization.
For selected patients, a clinician may consider ketamine within a broader pain-management plan. But chronic pain is rarely one-dimensional. Sleep, depression, anxiety, trauma, physical conditioning, inflammation, injury, medical disease, and substance use can all influence how pain is experienced.
Reducing pain intensity temporarily is therefore not necessarily the same as improving mobility, function, sleep, or quality of life over time.
Depending on the underlying condition, alternatives or complementary approaches may include physical therapy, therapeutic exercise, nonopioid medications, cognitive behavioral therapy, mindfulness-based approaches, rehabilitation, and coordinated multidisciplinary pain care.
Is Ketamine Addictive?
Ketamine has recognized abuse and misuse potential. That does not mean everyone receiving medically supervised ketamine or Spravato will develop an addiction.
The distinction matters.
Risk becomes more concerning when someone begins using ketamine more frequently than intended, seeking larger amounts, obtaining it from nonmedical sources, hiding use, becoming preoccupied with its dissociative effects, or continuing despite physical, psychological, financial, occupational, or relationship problems.
For some people, dissociation itself can become reinforcing. A person living with severe depression, anxiety, trauma, grief, or chronic pain may find temporary emotional detachment intensely relieving. If that relief becomes something the person increasingly seeks outside a structured treatment plan, the relationship with the drug can begin to change.
If substance use and mental health symptoms are influencing one another, dual diagnosis treatment can help address both sides of the problem rather than treating them as unrelated conditions.
Why Does Spravato Have Abuse and Misuse Warnings?
Spravato’s controlled administration is one of the clearest differences between FDA-approved esketamine treatment and unsupervised ketamine use.
Esketamine can produce dissociation and other psychoactive effects. Its prescribing information therefore addresses abuse and misuse, and people at higher risk require careful consideration and monitoring.
A history of substance use disorder does not automatically mean someone can never receive a medication with abuse potential. It does mean the treatment team should consider the person’s recovery history, current stability, psychiatric condition, other medications and substances, treatment alternatives, and potential benefits and risks.
What Are the Risks of Ketamine?
Dissociation
Ketamine can make someone feel disconnected from their body, thoughts, emotions, or surroundings. Outside a monitored setting, profound dissociation can contribute to confusion, injuries, or unsafe decisions.
Sedation and Impairment
Ketamine and esketamine can affect alertness, coordination, reaction time, and judgment. These effects help explain why driving restrictions and post-dose monitoring matter.
Blood Pressure Changes
Ketamine and esketamine can increase blood pressure. Screening is important because cardiovascular and cerebrovascular conditions may affect treatment decisions.
Cognitive Effects
Frequent or heavy ketamine exposure has raised concerns involving memory, attention, and other cognitive functions, especially when use becomes chronic or uncontrolled.
Abuse and Misuse
Ketamine is a Schedule III controlled substance and has recognized abuse potential. Risk becomes more concerning when use escalates or shifts toward intoxication and dissociation.
Polysubstance Risks
Recreational ketamine may be combined with alcohol, opioids, benzodiazepines, or other drugs, creating circumstances very different from controlled medical administration. Combining psychoactive substances can make impairment and medical complications more difficult to predict.
What Is a K-Hole?
“K-hole” is an informal term describing an intense dissociative state associated with ketamine. Someone may feel profoundly disconnected from their body or surroundings, while communication and movement can become difficult.
Perception of time and space can become distorted, and a person may experience hallucinations, confusion, memory impairment, or a frightening sense of separation from reality.
The term is sometimes used casually, but severe dissociation can be dangerous. It should not be confused with the carefully monitored effects that may occur during legitimate medical treatment.
Can Ketamine Damage the Bladder?
One of the less widely understood complications of frequent ketamine misuse involves the urinary system. Chronic heavy use has been associated with ketamine-induced cystitis, sometimes called ketamine bladder syndrome.
Urinary Symptoms
Symptoms may include frequent urination, urgency, painful urination, blood in the urine, and reduced bladder capacity.
Pelvic and Bladder Pain
Ketamine-related urinary damage can produce substantial pelvic discomfort and chronic bladder pain.
More Serious Complications
Severe disease can extend beyond the bladder and may affect other parts of the urinary system, including the kidneys.
Examples of Harm From Chronic Ketamine Misuse
Published medical literature contains real-world cases demonstrating that repeated recreational ketamine use can cause substantial physical harm.
Daily Use and Urinary Damage
Case reports have described people using ketamine daily who later developed severe urinary symptoms, bladder-wall abnormalities, and ketamine-induced cystitis requiring urological care.
Escalating Use to Manage Pain
Other reports describe people increasing ketamine use while attempting to manage pain that may itself have been related to chronic ketamine exposure, creating a harmful feedback loop.
Severe Abdominal Pain
Chronic nonmedical ketamine use has also been associated with severe abdominal or back pain sometimes referred to informally as “K-cramps.”
What Happens When Ketamine Becomes a Way to Escape?
This may be one of the most important issues for people living with both mental health symptoms and substance use.
Dissociation can temporarily create distance from emotional or physical pain. For someone experiencing depression, trauma or PTSD, grief, anxiety, or chronic pain, that experience may feel like relief.
But temporary detachment is different from developing sustainable coping skills.
A problematic cycle can develop when distress increases, ketamine creates temporary distance from the distress, the effect fades, and the person increasingly wants to recreate the dissociative experience.
Evidence-based therapies such as cognitive behavioral therapy and dialectical behavior therapy can help people develop practical coping skills, emotional regulation, distress tolerance, and healthier responses to triggers.
Is At-Home Ketamine Therapy the Same as Spravato?
No. The phrase “at-home ketamine therapy” can describe very different arrangements, including legitimately prescribed compounded products as well as unsafe or unlawfully marketed products.
Spravato is not an at-home treatment. Its FDA-required framework involves administration in certified healthcare settings under direct observation with monitoring afterward.
Consumers should be cautious about websites offering ketamine products without appropriate medical evaluation, legitimate prescription requirements, or clear information about the product’s source.
The FDA’s June 2026 warning letters are a timely reminder that a professional-looking website does not establish that a ketamine product is FDA-approved, lawfully marketed, or appropriate for a particular patient.
Alternatives to Ketamine for Depression
Ketamine-based treatments are not the only options for depression. The right approach depends on the person’s diagnosis, previous treatment, symptoms, medical history, substance-use history, and individual response.
Cognitive Behavioral Therapy
CBT helps people identify connections between thoughts, emotions, and behaviors while developing more effective responses to depressive thinking and stress.
Explore CBTBehavioral Activation
Behavioral activation helps people gradually reconnect with meaningful activities, responsibilities, relationships, and routines that depression may have disrupted.
Individual Therapy
Individual therapy can explore depression, grief, trauma, relationship stress, substance-use triggers, and patterns that contribute to emotional distress.
Individual TherapyIntegrated Dual Diagnosis Care
When depression occurs alongside alcohol or drug use, integrated treatment can address both problems within one coordinated care plan.
Dual Diagnosis TreatmentAlternatives to Ketamine for Chronic Pain
Chronic pain treatment may involve multiple strategies rather than relying exclusively on a psychoactive medication.
Physical Therapy
Physical rehabilitation can improve mobility, strength, flexibility, function, and confidence depending on the underlying condition.
Therapeutic Exercise
Appropriate movement, resistance exercise, aerobic activity, or aquatic exercise may improve function and reduce disability for some conditions.
CBT for Chronic Pain
CBT can help patients identify patterns involving pain, fear, avoidance, stress, and activity while developing healthier coping strategies.
Mindfulness and Stress Reduction
Mindfulness-based approaches may help reduce stress reactivity and change the way some patients respond to persistent discomfort.
Nonopioid Medication Options
Depending on the diagnosis, clinicians may consider nonopioid medications or topical treatments as part of an individualized pain plan.
Integrated Pain Care
Some people benefit from coordinated medical care, rehabilitation, behavioral therapy, sleep support, and lifestyle interventions.
When Depression, Chronic Pain and Substance Use Overlap
Depression, pain, and substance use can reinforce one another. A person experiencing persistent pain may begin using alcohol, opioids, benzodiazepines, ketamine, or other substances in an attempt to feel better. Someone experiencing severe depression may use substances to numb emotional distress.
Substance use can then worsen sleep, relationships, physical health, mood stability, and everyday functioning.
This is why treating only the substance without addressing depression or pain can leave important relapse triggers unresolved. It is also why treating depression while overlooking problematic substance use can create a different set of risks.
Tulip Hill Healthcare’s dual diagnosis treatment is designed to address addiction and co-occurring mental health concerns within a coordinated plan.
Questions to Ask Before Starting Ketamine-Based Treatment
What Exactly Am I Receiving?
Ask whether the treatment is FDA-approved Spravato, off-label ketamine, a compounded formulation, or another product.
Who Is Monitoring Treatment?
Understand who evaluates you, supervises treatment, monitors side effects, and determines whether treatment should be changed or stopped.
What Is the Long-Term Plan?
Ask whether psychotherapy, psychiatric care, physical rehabilitation, lifestyle changes, or other treatments are part of the plan.
How Does My Addiction History Matter?
People with current or previous substance misuse should discuss cravings, compulsive patterns, recovery stability, and abuse risk openly with the treating clinician.
Signs Ketamine Use May Be Becoming a Problem
Ketamine use deserves closer evaluation when someone begins using more than intended, increasing how often they use it, seeking ketamine outside legitimate medical treatment, obtaining products from questionable online sources, or becoming increasingly focused on intoxication or dissociation.
Other warning signs can include hiding or minimizing use, combining ketamine with other substances, continuing despite bladder or abdominal symptoms, experiencing cognitive or emotional problems, or feeling unable to cope with depression, trauma, anxiety, or pain without ketamine.
A person does not need to wait for severe addiction or a medical emergency before asking for help.
What Happens When You Stop Heavy Ketamine Use?
People who use ketamine frequently or compulsively may experience difficulty stopping, but the medical literature does not describe one uniform withdrawal syndrome that occurs in every person.
Research on ketamine use disorder has reported craving, low mood, anxiety, irritability, sleep disturbance, and other psychological symptoms during abstinence in some people. Physical withdrawal symptoms appear to be less consistently described than they are with substances such as alcohol, opioids, or benzodiazepines.
Another challenge is separating withdrawal-like symptoms from the return of the depression, anxiety, trauma symptoms, or pain that contributed to ketamine use in the first place.
Anyone using ketamine heavily, using multiple substances, or finding it difficult to stop should consider a clinical assessment rather than assuming they need to manage the process alone. An assessment can identify co-occurring substance use, psychiatric symptoms, medical complications, and the appropriate level of care.
Spravato Treatment Is Not the Same as Ketamine Addiction
Conversations about ketamine misuse should not stigmatize people receiving legitimate psychiatric treatment.
Spravato has an FDA-approved role for specific depressive conditions. At the same time, its restricted administration requirements and warnings concerning abuse and misuse should not be ignored.
Both things can be true: a medication can offer meaningful benefit for appropriately selected patients while requiring substantial safeguards.
That distinction is more medically responsible than describing ketamine-derived therapies as either miracle treatments or inherently dangerous drugs.
Treatment When Mental Health and Substance Use Intersect
When substance use develops alongside depression, trauma, anxiety, chronic pain, or another mental health concern, addressing only one side of the problem may not be enough.
Tulip Hill Healthcare helps individuals and families navigate addiction treatment programs and behavioral health care across a continuum of care. Depending on clinical needs and facility availability, treatment may include detox, residential treatment, partial hospitalization, intensive outpatient care, outpatient treatment, dual diagnosis services, and continuing recovery support.
Dual Diagnosis Treatment
Integrated treatment can address substance use alongside depression, anxiety, trauma-related symptoms, medication needs, and relapse risk.
Explore Dual DiagnosisDrug & Alcohol Rehab
Compare addiction-treatment options and levels of care available across the Tulip Hill Healthcare network.
Explore RehabPrescription Drug Detox
Learn how medical stabilization and integrated mental health care can support people struggling with prescription medication misuse or polysubstance use.
Prescription Drug DetoxFind a Treatment Facility
Review Tulip Hill Healthcare network locations and available treatment settings across Tennessee, Kentucky, and New Jersey.
View FacilitiesFrequently Asked Questions About Spravato and Ketamine
Is Spravato the same as ketamine?
No. Spravato contains esketamine, which is chemically related to ketamine. Spravato is an FDA-approved nasal medication with specific depression indications and is administered through a restricted healthcare framework.
Is ketamine FDA-approved for depression?
Ketamine itself is FDA-approved as an anesthetic and is not FDA-approved specifically for psychiatric disorders. Clinicians may use ketamine off-label in certain circumstances.
Is Spravato FDA-approved for depression?
Yes. Spravato has specific FDA-approved indications involving treatment-resistant depression and depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior.
Why does Spravato require monitoring?
Spravato can cause sedation, dissociation, respiratory depression, and blood-pressure changes and has potential for abuse and misuse. FDA requires administration through the Spravato REMS and monitoring for at least two hours after treatment.
Can Spravato be addictive?
Spravato’s prescribing information includes warnings concerning abuse and misuse. This does not mean everyone receiving treatment develops addiction. Appropriate patient selection and monitoring are important.
Can ketamine therapy lead to addiction?
Ketamine has abuse potential. Risk becomes more concerning when use escalates, occurs outside medical supervision, becomes focused on intoxication or dissociation, or continues despite harmful consequences.
What is a K-hole?
A K-hole is an informal term for a profound dissociative state associated with ketamine. It may involve severe detachment, confusion, hallucinations, altered perception, impaired movement, and memory problems.
What does ketamine do to the bladder?
Frequent heavy ketamine use has been associated with ketamine-induced cystitis, which may cause urinary frequency, urgency, painful urination, pelvic pain, blood in the urine, and potentially serious urinary complications.
What are K-cramps?
K-cramps is an informal term used for severe abdominal discomfort reported by some people who frequently use ketamine. Significant abdominal pain should receive appropriate medical evaluation.
Is compounded ketamine the same as Spravato?
No. Compounded ketamine products and FDA-approved Spravato are different products operating under different regulatory frameworks. Compounded drugs do not undergo FDA premarket approval in the same manner as FDA-approved medications.
Is at-home ketamine the same as Spravato?
No. FDA-approved Spravato is administered in certified healthcare settings under its REMS requirements rather than being dispensed for unsupervised administration at home.
What therapies can help depression without ketamine?
Depending on the person, treatment may include cognitive behavioral therapy, behavioral activation, individual therapy, medication management, mindfulness-based approaches, and integrated dual diagnosis treatment when substance use is also present.
Should someone with a history of addiction receive Spravato?
That decision should be individualized by qualified healthcare professionals. A history of substance use disorder does not automatically determine whether treatment is appropriate, but abuse and misuse risk should be considered carefully.
What happens when someone stops heavy ketamine use?
There is not one clearly defined withdrawal syndrome that occurs in every person. Some people with heavy or compulsive ketamine use report cravings, low mood, anxiety, irritability, sleep problems, or other psychological symptoms after stopping. A clinical assessment can help distinguish withdrawal-related concerns from the return of underlying mental health or pain symptoms.
Where can someone get help for problematic ketamine use?
People who are losing control of ketamine or other substance use can seek an addiction assessment. When depression, anxiety, trauma, or chronic pain is also present, integrated behavioral health and substance use treatment may be particularly important.
The Bottom Line
Spravato, medically administered ketamine, compounded ketamine, and recreational ketamine are not interchangeable.
Spravato represents an FDA-approved esketamine treatment with specific indications and substantial safeguards. Ketamine remains an important anesthetic and may be used off-label in certain clinical circumstances, but it is not FDA-approved specifically for psychiatric disorders.
Ketamine also has recognized misuse potential, and repeated uncontrolled use can lead to serious consequences.
People considering ketamine-based treatment should understand what medication they are receiving, whether the use is FDA-approved or off-label, how treatment will be monitored, what risks apply to them, and what alternatives are available.
For people already living with addiction or in recovery, those questions deserve particular attention.
Clinical Sources and References
U.S. Food and Drug Administration. Internet Pharmacy Warning Letters, including ketamine-related warning letters issued June 23, 2026. View FDA warning letters.
U.S. Food and Drug Administration. Keta Med Lab warning letter, June 23, 2026. The FDA distinguishes approved ketamine anesthetic products from Spravato and states that ketamine is not FDA-approved for psychiatric disorders. View FDA source.
U.S. Food and Drug Administration. Spravato prescribing information. Current labeling includes treatment-resistant depression in adults as monotherapy or with an oral antidepressant and describes boxed warnings and REMS requirements. View prescribing information.
U.S. Food and Drug Administration. Ketamine Troche Store warning letter, June 23, 2026, describing unapproved ketamine products and current Spravato REMS requirements. View FDA source.
European Neuropsychopharmacology. Long-term treatment with esketamine nasal spray in patients with treatment-resistant depression: Results from the ESCAPE-LTE study. Volume 107, June 2026, 112801. View study.
Urology Case Reports / PubMed. Ketamine-induced cystitis: A case report and literature review. The report describes a 46-year-old man with seven months of daily recreational ketamine use who developed substantial urinary tract abnormalities and ketamine-induced cystitis. View study.
Clinical Practice and Cases in Emergency Medicine / PubMed. Abdominal Pain and Dysuria Secondary to Chronic Recreational Ketamine Use: A Case Report on K-cramps. The report describes severe abdominal pain and urinary symptoms associated with chronic high-dose ketamine use. View study.
Journal of Substance Use and Addiction Treatment. Treatment and management approaches for ketamine misuse: A systematic review of medical interventions. Published in 2026, the review describes the growing clinical relevance of ketamine misuse while emphasizing that evidence for treatment approaches remains fragmented. View study.
Journal of Addiction Medicine. The Pharmacological Management of Ketamine Use Disorder: A Systematic Review. The review identified studies addressing ketamine intoxication, withdrawal, craving, and relapse prevention, while concluding that the overall evidence remains very limited. View study.
Medical Disclaimer: This article is for educational purposes and is not intended to diagnose a condition, recommend stopping a prescribed medication, or replace individualized medical advice. Do not discontinue Spravato, ketamine, or another prescribed treatment without speaking with the healthcare professional managing your care.
